drugset / Trial / NCT03589027
Darunavir and Rilpivirine Interactions With Levonorgestrel Implant
Phase 2
Unknown
60 enrolled
Makerere University
University of Liverpool · collabUniversity of Nebraska · collabUniversity of Pittsburgh · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the pharmacokinetic properties of Rilpivirine and Darunavir when used in combination with Levonorgestrel
Timeline
- Start
- 2018-08-07
- Primary completion
- 2019-06
- Completion
- 2020-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darunavir | Small molecule | 600 mg | Oral |
| Subject | Levonorgestrel | Small molecule | 150 mg | Other |
| Subject | Rilpivirine | Small molecule | 25 mg | Oral |
| Background | Ritonavir | Other / unclassified | 100 mg | Oral |